Company profile for Wanbang Biopharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diab...
Wanbang Biopharmaceuticals is a leading anti-diabetic pharmaceutical company in China and a core member of Fosun Group (SH600196; HK02196). Wanbang Biopharma has been focusing at the development, manufacture and sale of pharmaceuticals to address the unmet medical needs in the area of diabetic disease since its establishment in 1981.As the pioneer insulin producer in China, Wanbang has been developed into the largest anti-diabetic pharmaceutical provider of China with a comprehensive product portfolio that covers a wide range of anti-diabetic drugs, serving for more than eight million diabetic patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
South of Dongshan, Comprehensive Area, Jinshanqiao Development Zone, Xuzhou, J...
Telephone
Telephone
+86 516 8381 7058
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217638

FDA
12 Jun 2024
China’s Wanbang expands partnership with Canadian biotech Sirona
China’s Wanbang expands partnership with Canadian biotech Sirona

24 Nov 2022

// Gabrielle Masson FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/wanbang-sirona-biochem-pen-new-licensing-pact-non-insulin-diabetes-candidate

Gabrielle Masson FIERCEBIOTECH
24 Nov 2022

ABOUT THIS PAGE

Contact Wanbang Biopharmaceuticals and get a quotation

Wanbang Biopharmaceuticals is a supplier offers 14 products (APIs, Excipients or Intermediates).

Find a price of Febuxostat bulk with DMF offered by Wanbang Biopharmaceuticals

Find a price of Pitavastatin bulk with DMF offered by Wanbang Biopharmaceuticals

Find a price of Aceglutamide bulk offered by Wanbang Biopharmaceuticals

Find a price of Apixaban bulk offered by Wanbang Biopharmaceuticals

Find a price of Calcium Dobesilate bulk offered by Wanbang Biopharmaceuticals

Find a price of Fasudil bulk offered by Wanbang Biopharmaceuticals

Find a price of Glimepiride bulk offered by Wanbang Biopharmaceuticals

Find a price of Heparin Sodium bulk offered by Wanbang Biopharmaceuticals

Find a price of Insulin Lispro bulk offered by Wanbang Biopharmaceuticals

Find a price of Insulin, Regular, Pork bulk offered by Wanbang Biopharmaceuticals

Find a price of Perphenazine bulk offered by Wanbang Biopharmaceuticals

Find a price of Propylthiouracil bulk offered by Wanbang Biopharmaceuticals

Find a price of Tetracaine Hydrochloride bulk offered by Wanbang Biopharmaceuticals

Find a price of Ticagrelor bulk offered by Wanbang Biopharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty